Lynas share price surges on U.S. tender news

The Lynas Corporation Ltd (ASX:LYC) share price is surging higher again on Friday. Here's why its shares are up 14% in just two days…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Lynas Corporation Ltd (ASX: LYC) share price is pushing higher again on Friday and is one of the best performers on the ASX 200.

At the time of writing the rare earths producer's shares are up 4% to $2.46.

This means Lynas' shares are now up a sizeable 14.5% over the last two days. Which has stretched its year to date gain to an impressive 60%.

Why is the Lynas share price charging higher?

Lynas' shares have been on fire this week after the U.S. Army revealed that it is looking to fund the construction of a rare earths plant for weapons development.

According to Reuters, the U.S. Army is intent on making its first financial investment into commercial-scale rare earths production since World War Two.

This appears to be due to China's dominant position in rare earths and concerns that it will use it as geopolitical leverage. Especially given their use in the production of military weapons and electronics.

Reuters notes that the U.S. military is offering to fund up to two-thirds of a refiner's cost. Which certainly makes it an attractive opportunity for a rare earths producer such as Lynas.

And given that Lynas is the largest rare earths producer outside China, it is arguably in a strong position to win the government tender if it bids for it.

Lynas response.

This morning Lynas responded to speculation that it will be bidding for the tender.

In a brief statement the company advised: "The tender period has not yet closed. Lynas would expect to submit a compliant tender."

The tender period is believed to close on December 16, which means Lynas may be working overtime this weekend to get one submitted at the start of next week.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »